Abstract

Direct irradiation may cause malfunctioning of cardiac implantable electronic devices (CIEDs). Therefore, a treatment plan that does not involve direct irradiation of CIEDs should be formulated. However, CIEDs may be directly exposed to radiation because of the sudden intrafractional movement of the patient. The probability of CIED malfunction reportedly depends on the dose rate; however, reports are only limited to dose rates ≤8 Gy/min. The purpose of this study was to investigate the effect of X-ray dose rates >8 Gy/min on CIED function. Four CIEDs were placed at the center of the radiation field and irradiated using 6 MV X-ray with flattening filter free (6 MV FFF) and 10 MV X-ray with flattening filter free (10 MV FFF). The dose rate was 4–14 Gy/min for the 6 MV FFF and 4–24 Gy/min for 10 MV FFF beams. CIED operation was evaluated with an electrocardiogram during each irradiation. Three CIEDs malfunctioned in the 6 MV FFF condition, and all four CIEDs malfunctioned in the 10 MV FFF condition, when the dose rate was >8 Gy/min. Pacing inhibition was the malfunction observed in all four CIEDs. Malfunction occurred simultaneously along with irradiation and simultaneously returned to normal function on stopping the irradiation. An X-ray dose rate >8 Gy/min caused a temporary malfunction due to interference. Therefore, clinicians should be aware of the risk of malfunction and manage patient movement when an X-ray dose rate >8 Gy/min is used for patients with CIEDs.

INTRODUCTION

Cardiac implantable electronic devices (CIEDs) are used for the non-pharmacological management of cardiac arrhythmias. CIEDs include pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy devices and cardiac resynchronization therapy with implantable cardioverter-defibrillators. A CIED consists of a main unit, which is composed of a control circuit, a semiconductor element and a battery, and a lead to send and receive electrical signals to the heart [1]. Several reports have stated that direct radiation exposure to CIEDs caused malfunctions (i.e. permanent device damage, power-on reset, pacing inhibition and inappropriate shock) [2–4]. These reports showed that radiation exposure to the control circuit caused the malfunction [5, 6]. Because radiation exposure to silicon dioxide (SiO2), which is used to fabricate the complementary metal oxide semiconductor (CMOS) in the control circuit, leads to the formation of electron-hole pairs in SiO2, the electron hole creates transient or permanent aberrant electrical pathways [5, 6]. The overcurrent due to the aberrant electrical pathways is recognized as false cardiac activity, and CIED malfunctions are thought to occur. Since a CMOS that does not use SiO2 has not been developed yet, it is impossible to prevent the generation of overcurrent that occurs when the control circuit is exposed to ionizing radiation. Although technical improvements have been made to reduce the influence of overcurrent on the control circuit by the use of protection software, the basic structure of CIEDs has remained unchanged [7]. Therefore, the issue of malfunctioning caused by irradiation to CIEDs still exists.

A report by Task Group 203 for management of radiotherapy patients with implanted cardiac pacemakers and defibrillators was published by the American Association of Physicists in Medicine in 2019, it described the causes of radiation-induced malfunctions as cumulative dose, neutrons and dose rates [8]. Several studies on cumulative dose reported that implantable cardioverter-defibrillators failed at ≤2.5 Gy, and that pacemakers failed at ≤5 Gy [4, 5, 9–11]. Furthermore, the probability of CIED malfunction was 0% for non-neutron-producing radiation, indicating that neutrons are involved in the occurrence of malfunctions [12–15]. However, although there are some reports on cumulative doses and neutrons, there are few reports on dose rates. To the best of our knowledge, the only report on the relationship between CIED malfunction and dose rate is by Mouton et al. [10]. According to their report, malfunctions were observed in 0, 4, 14 and 68 out of 96 pacemakers, when dose rates were ≤0.2, ≤1.0, ≤4.0 and ≤8.0 Gy/min, respectively. On the other hand, even if the dose rate was 8 Gy/min, no malfunction was observed in 10 of 96 pacemakers. These results indicate that the probability of CIED malfunction depends on the dose rate. However, high-energy X-rays used in conventional radiotherapy have been equipped with a flattening filter (FF) in the treatment head of a medical accelerator to ensure a flat dose profile, so that the maximum dose rate is ≤8 Gy/min. Hence, the existing data only document the relationship between the probability of malfunction of CIEDs and high-energy X-ray dose rates ≤8 Gy/min and there is no evidence for dose rates >8 Gy/min [8, 10]. Flattening filter-free (FFF) beams, which can deliver high dose rates of radiation by removing the FF, have recently been used in clinical practice. Thus, the effect of X-ray dose rates >8 Gy/min on CIED operation has not been investigated. X-ray dose rates > 8Gy/min have been used for stereotactic radiotherapy to the head and neck, cervical spine and lung, which are in close proximity to the CIED [16]. Guidelines for the management of patients with CIEDs recommend placing the CIED outside the field of radiation [8, 17–20]. However, sudden intrafractional movement of the patient may lead to temporary direct irradiation to the CIED. Thus, it is necessary to report the relationship between dose rate >8 Gy/min and CIED malfunction. The purpose of this study was to investigate the effect of X-ray dose rates >8 Gy/min on CIEDs by evaluating CIED function.

MATERIALS AND METHODS

Models and settings of CIEDs

We used four CIEDs (two pacemakers and two cardiac resynchronization therapy devices). The CIEDs included Sensia (Medtronic, Minneapolis, MN, USA), INSYNC III (Medtronic, Minneapolis, MN, USA), Assurity Magnetic Resonance Imaging (MRI) (St. Jude Medical, Sylmar, CA, USA) and FRONTIER II (St. Jude Medical, Sylmar, CA, USA). Table 1 shows the manufacturer, model and type of CIED. Each CIED was set to the AAI mode, the atrial pulse amplitude was set at 7.5 V, the rate setting was 40 pulses/min, the sensitivity was set to the ‘most sensitive’ setting and the sensing polarity was bipolar. The CIED was connected to a Y-adapter (5866-38 M, Medtronic, Minneapolis, MN, USA) to pace the pulse output. The pacemaker (Sensia) with the pacing lead (Attain Bipolar OTW 4194, Medtronic, Minneapolis, MN, USA), was used as a pseudo beat generator with a rate setting of 70 pulses/min. The CIED function during each irradiation was evaluated with an electrocardiogram (ECG) with a patient monitoring system (BSM-2401, NIHON KOHDEN Corp., Tokyo, Japan).

Table 1

Models of CIEDs

ManufacturerModelTypea
MedtronicSensiaPM
MedtronicINSYNC IIICRT
St. Jude MedicalAssurity MRIPM
St. Jude MedicalFRONTIER IICRT
ManufacturerModelTypea
MedtronicSensiaPM
MedtronicINSYNC IIICRT
St. Jude MedicalAssurity MRIPM
St. Jude MedicalFRONTIER IICRT

aPM = pacemaker; CRT = cardiac resynchronization therapy device; MRI = magnetic resonance imaging.

Table 1

Models of CIEDs

ManufacturerModelTypea
MedtronicSensiaPM
MedtronicINSYNC IIICRT
St. Jude MedicalAssurity MRIPM
St. Jude MedicalFRONTIER IICRT
ManufacturerModelTypea
MedtronicSensiaPM
MedtronicINSYNC IIICRT
St. Jude MedicalAssurity MRIPM
St. Jude MedicalFRONTIER IICRT

aPM = pacemaker; CRT = cardiac resynchronization therapy device; MRI = magnetic resonance imaging.

Installation of CIEDs

The CIED was placed on a 20-cm stack of tissue equivalent phantoms (Tough-Water, Kyoto Kagaku Co. Ltd, Kyoto, Japan) on a treatment couch top. The field size was 10 × 10 |${\mathrm{cm}}^2$| at the phantom surface, the source-to-surface distance was 100 cm, and the CIED was placed at the center of the radiation field. The tip of the Y-adapter for pacing pulse output was inserted in a water tank filled with 0.18 wt% saline, simulating the electrical conductivity of the human body, and the pseudo beat generator was placed at the bottom of the water tank. Furthermore, the electrodes installed in the water tank for recording the ECG were placed more than 2 m away from the center of the radiation field to prevent direct irradiation. The experimental scheme of the CIED is shown in Fig. 1.

Experimental scheme of a CIED. A, The center of the radiation field at the beam isocenter of a 10 × 10 cm2 field at the surface of tissue equivalent phantoms with a source-to-surface distance of 100 cm. The pacing pulse output for the Y adapter was recorded by the electrocardiogram via electrodes installed in the water tank.
Fig. 1.

Experimental scheme of a CIED. A, The center of the radiation field at the beam isocenter of a 10 × 10 cm2 field at the surface of tissue equivalent phantoms with a source-to-surface distance of 100 cm. The pacing pulse output for the Y adapter was recorded by the electrocardiogram via electrodes installed in the water tank.

Irradiation conditions of CIEDs

Irradiation was performed with an FFF beam using a TrueBeamSTx (Varian Medical Systems, Palo Alto, CA, USA). The X-ray energy of the FFF beam was 6 MV FFF and 10 MV FFF. Dose rates of 4, 6, 8, 10, 12 and 14 Gy/min were used for the 6 MV FFF beam and 4, 8, 12, 16, 20 and 24 Gy/min for the 10 MV FFF beam.

Test of CIED malfunction

We evaluated transient CIED malfunctions in this study, since we assumed the condition of temporary direct X-ray exposure to the CIED. Transient malfunctions caused by radiation to the CIED have different effects, based on the patient’s CIED-dependency. We performed the inhibition test for the condition of high CIED-dependency and the asynchronous test for the condition of low CIED-dependency.

Inhibition test

The inhibition test was performed without the input pulse of the pseudo beat generator described under Installation of CIEDs. The ECG was recorded when the CIED was irradiated by the FFF beam with the parameters described under Irradiation conditions of CIEDs. We evaluated the presence or absence of the pacing pulses in the CIEDs, i.e. the pacing inhibition.

Asynchronous test

The asynchronous test was performed with an input pulse obtained from the pseudo beat generator, as described under Installation of CIEDs. The ECG was recorded when the CIED was irradiated by the FFF beam with the parameters described under Irradiation conditions of CIEDs. We evaluated the presence or absence of pulses, unrelated to the pacing pulses of the pseudo beat generator, i.e. the asynchronous pacing.

RESULTS

Inhibition test

The results of the inhibition tests of 6 MV FFF and 10 MV FFF are depicted in Tables 2 and 3, respectively. In the 6 MV FFF condition, pacing inhibition was observed in three of four CIEDs and in all four CIEDs, when the dose rates were 4–12 Gy/min and ≥14 Gy/min, respectively. In the 10 MV FFF condition, pacing inhibition was observed in three of four CIEDs and in all four CIEDs, when the dose rates were 4 Gy/min and 8–24 Gy/min, respectively. Fig. 2 shows an example of an ECG in normal function and pacing inhibition. Pacing inhibition occurred simultaneously with irradiation and returned to normal function simultaneously on stopping the irradiation.

Asynchronous test

The results of the asynchronous tests of the 6 MV FFF and 10 MV FFF are depicted in Tables 4 and 5, respectively. In the 6 MV FFF condition, asynchronous pacing was observed in one of four CIEDs and two of four CIEDs, when the dose rate was 4–8 Gy/min and ≥10 Gy/min, respectively. In the 10 MV FFF condition, asynchronous pacing was observed in two of four CIEDs, when the dose rate was 4–24 Gy/min. Fig. 3 shows an example of an ECG in normal function and asynchronous pacing. The asynchronous pacing occurred simultaneously with irradiation and returned to the normal function simultaneously on stopping the irradiation.

Table 2

Summary of inhibition test results in 6 MV FFF. A dose rate ≥14 Gy/min induced pacing inhibition in all CIEDs. Assurity MRI induced pacing inhibition dependent on the dose rate. I, Pacing inhibition; −, normal operation

Dose rate (Gy/min)468101214
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude medicalAssurity MRII
St. Jude medicalFRONTIER IIIIIIII
Dose rate (Gy/min)468101214
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude medicalAssurity MRII
St. Jude medicalFRONTIER IIIIIIII
Table 2

Summary of inhibition test results in 6 MV FFF. A dose rate ≥14 Gy/min induced pacing inhibition in all CIEDs. Assurity MRI induced pacing inhibition dependent on the dose rate. I, Pacing inhibition; −, normal operation

Dose rate (Gy/min)468101214
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude medicalAssurity MRII
St. Jude medicalFRONTIER IIIIIIII
Dose rate (Gy/min)468101214
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude medicalAssurity MRII
St. Jude medicalFRONTIER IIIIIIII
Table 3

Summary of inhibition test results for 10 MV FFF. A dose rate ≥8 Gy/min induced pacing inhibition in all CIEDs. Assurity MRI induced pacing inhibition dependent on the dose rate. I, Pacing inhibition; −, normal operation

Dose rate (Gy/min)4812162024
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude MedicalAssurity MRIIIIII
St. Jude MedicalFRONTIER IIIIIIII
Dose rate (Gy/min)4812162024
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude MedicalAssurity MRIIIIII
St. Jude MedicalFRONTIER IIIIIIII
Table 3

Summary of inhibition test results for 10 MV FFF. A dose rate ≥8 Gy/min induced pacing inhibition in all CIEDs. Assurity MRI induced pacing inhibition dependent on the dose rate. I, Pacing inhibition; −, normal operation

Dose rate (Gy/min)4812162024
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude MedicalAssurity MRIIIIII
St. Jude MedicalFRONTIER IIIIIIII
Dose rate (Gy/min)4812162024
MedtronicSensiaIIIIII
MedtronicINSYNC IIIIIIIII
St. Jude MedicalAssurity MRIIIIII
St. Jude MedicalFRONTIER IIIIIIII
ECG output recording of CIEDs during irradiation in an inhibition test. In normal operation only the pacing pulse was recorded. If pacing inhibition occurred, pacing pulse was not recorded only during radiation exposure to the CIED.
Fig. 2.

ECG output recording of CIEDs during irradiation in an inhibition test. In normal operation only the pacing pulse was recorded. If pacing inhibition occurred, pacing pulse was not recorded only during radiation exposure to the CIED.

Table 4

Summary of asynchronous test results for 6 MV FFF. A dose rate ≥10 Gy/min induced asynchronous pacing in two of four CIEDs, but not in the other CIEDs. Sensia induced asynchronous pacing dependent on the dose rate. A, Asynchronous pacing; −, normal operation

Dose rate (Gy/min)468101214
MedtronicSensiaAAA
MedtronicINSYNC IIIAAAAAA
St. Jude MedicalAssurity MRI
St. Jude MedicalFRONTIER II
Dose rate (Gy/min)468101214
MedtronicSensiaAAA
MedtronicINSYNC IIIAAAAAA
St. Jude MedicalAssurity MRI
St. Jude MedicalFRONTIER II
Table 4

Summary of asynchronous test results for 6 MV FFF. A dose rate ≥10 Gy/min induced asynchronous pacing in two of four CIEDs, but not in the other CIEDs. Sensia induced asynchronous pacing dependent on the dose rate. A, Asynchronous pacing; −, normal operation

Dose rate (Gy/min)468101214
MedtronicSensiaAAA
MedtronicINSYNC IIIAAAAAA
St. Jude MedicalAssurity MRI
St. Jude MedicalFRONTIER II
Dose rate (Gy/min)468101214
MedtronicSensiaAAA
MedtronicINSYNC IIIAAAAAA
St. Jude MedicalAssurity MRI
St. Jude MedicalFRONTIER II
Table 5

Summary of asynchronous test results for 10 MV FFF. A dose rate ≥4 Gy/min induced asynchronous pacing in two of four CIEDs, but not in the other CIEDs. A, Asynchronous pacing; −, normal operation

Dose rate (Gy/min)4812162024
MedtronicSensiaAAAAAA
MedtronicINSYNC IIIAAAAAA
St. Jude medicalAssurity MRI
St. Jude MedicalFRONTIER II
Dose rate (Gy/min)4812162024
MedtronicSensiaAAAAAA
MedtronicINSYNC IIIAAAAAA
St. Jude medicalAssurity MRI
St. Jude MedicalFRONTIER II
Table 5

Summary of asynchronous test results for 10 MV FFF. A dose rate ≥4 Gy/min induced asynchronous pacing in two of four CIEDs, but not in the other CIEDs. A, Asynchronous pacing; −, normal operation

Dose rate (Gy/min)4812162024
MedtronicSensiaAAAAAA
MedtronicINSYNC IIIAAAAAA
St. Jude medicalAssurity MRI
St. Jude MedicalFRONTIER II
Dose rate (Gy/min)4812162024
MedtronicSensiaAAAAAA
MedtronicINSYNC IIIAAAAAA
St. Jude medicalAssurity MRI
St. Jude MedicalFRONTIER II
ECG output recording of CIEDs during irradiation during asynchronous testing. In normal operation, only the pseudo beat was recorded. If asynchronous pacing occurred, the pacing that was unrelated to the pseudo beat was recorded only during radiation exposure to the CIED.
Fig. 3.

ECG output recording of CIEDs during irradiation during asynchronous testing. In normal operation, only the pseudo beat was recorded. If asynchronous pacing occurred, the pacing that was unrelated to the pseudo beat was recorded only during radiation exposure to the CIED.

DISCUSSION

We investigated the effect of X-ray dose rate >8 Gy/min on CIED function based on the results of the inhibition test and asynchronous test in this study, while considering the possibility of direct temporary CIED irradiation due to sudden patient movement.

This study similarly demonstrated that the probability of malfunction depended on the dose rate at dose rates of 4–24 Gy/min. (Tables 25). Malfunction was observed in three of four CIEDs in the 6 MV FFF condition, and in all four CIEDs in the 10 MV FFF condition, for dose rates >8 Gy/min. Malfunction was observed simultaneously with irradiation, which returned to normal function simultaneously when irradiation was stopped. Thus, it was transient and reversible malfunction, which did not require the replacement of CIEDs. The malfunction is thought to be caused by interference. Interference occurs if an overcurrent generated by X-ray exposure to the CMOS circuit is erroneously recognized as spontaneous cardiac activity. Interference has been reported not only with high-energy X-ray exposure, but also with diagnostic X-ray exposure [21, 22]. In this study, malfunction was observed on both inhibition and asynchronous testing. Thus, a dose rate >8 Gy/min may cause interference regardless of the patient’s CIED-dependency. However, a transient malfunction caused by interference can be eliminated by stopping irradiation. Moreover, dose rates ≤24 Gy/min did not cause significant malfunction, such as a power-on reset or loss of pacing.

It is suggested that radiation treatment plans should ensure that the CIED is outside the radiation field, in cases where the target area is close to the CIED [8, 17, 19] However, sudden intrafractional movement of the patient may cause direct radiation exposure to the CIED. Malfunction was observed simultaneously with irradiation in this study (Figs 2 and 3). Hence, even temporary exposure of the CIED to radiation due to a sudden intrafractional patient movement, may cause interference. Interference can cause pacing inhibition in patients with pacemakers and inappropriate shock in patients with implantable cardioverter defibrillators. These patients with CIED may experience palpitations, dizziness, loss of consciousness etc., although there have been few reports of clinical accidents caused by interference [23]. Interference occurred only with irradiation and returned to normal function immediately when radiation was stopped. The patient’s movement is constantly monitored during radiotherapy, and irradiation should be suspended immediately if abnormal patient movement is detected, thus the possibility that the malfunction is permanent is low [24]. Therefore, CIED malfunction due to interference, as observed in this study, is considered to have a low impact on patients.

On the other hand, the conditions of malfunctioning differed for each model of CIED (Tables 25). This could be attributed to the software that prevents malfunction and the material of the CMOS circuit, which differs for each CIED model and manufacturer. As the effects of X-ray dose rates >8 Gy/min on CIEDs differ, depending on the model and the manufacturer of the CIED, it is necessary to determine clinical management based on the patient’s CIED-dependency.

Furthermore, Mouton et al. reported that the probability of malfunctions increases with an increase in the dose rate for dose rates of 0.2–8 Gy/min [10]. However, in their report, it was possible that malfunctions occurred due to the effects of neutrons generated by an 18 MV photon or the effects of cumulative doses, and it was difficult to accurately evaluate the dose rate dependence of malfunctions [8]. Likewise, in this study, we could not determine whether malfunction in some models depends on the dose rate. Thus, further verification is necessary to clarify the relationship between the dose rate and the probability of CIED malfunction.

X-ray dose rates >8 Gy/min are frequently used in clinical practice, and there are several indications for stereotactic radiotherapy using X-ray dose rates >8 Gy/min for patients with CIED. Therefore, it is essential that clinicians administering radiotherapy (radiation oncologists, medical physicists, radiation therapists, nurses, etc.) be aware of the risk of malfunction caused by direct exposure of the CIEDs to X-ray dose rates >8 Gy/min and be able to adequately manage the patient’s movement during treatment.

This study was conducted using only the FFF beam. FFF beams can irradiate with a higher dose rate than the flattening filtered beam, while, the characteristics of the FFF beam are different from those of the flattening filtered beam [25]. Therefore, the possibility cannot be denied that the malfunction was caused by not only the dose rate, but also by the characteristics of the FFF beam.

This study investigated the effects of X-ray dose rates of 4–24 Gy/min on CIED function. An X-ray dose rate >8 Gy/min caused transient malfunction due to interference in three of four CIEDs. We confirmed that the probability of malfunction depended on the X-ray dose rate, even for dose rates >8 Gy/min, like earlier studies. Therefore, when an X-ray dose rate >8 Gy/min is used for patients with CIEDs, it is necessary to be aware of the risks of CIED malfunction and manage patient movement.

ACKNOWLEDGMENTS

We would like to thank Editage (www.editage.com) for English language editing and Ms Yukiko Kuru (Aichi Medical University) for language support. Some of the results of this study were presented at the Engineering and Physical Sciences in Medicine Conference and Asia-Oceania Congress of Medical Physics 2019, October 2019, Perth, Australia.

CONFLICT OF INTEREST

None declared.

REFERENCES

1.

Wilkoff
BL
,
Auricchio
A
,
Brugada
J
et al.
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations
.
Heart Rhythm
2008
;
5
:
907
25
.

2.

Tondato
F
,
Ng
DW
,
Srivathsan
K
et al.
Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction
.
Expert Rev Med Devices
2009
;
6
:
243
9
.

3.

Hashii
H
,
Hashimoto
T
,
Okawa
A
et al.
Comparison of the effects of high-energy photon beam irradiation (10 and 18 MV) on 2 types of implantable cardioverter-defibrillators
.
Int J Radiat Oncol Biol Phys
2013
;
85
:
840
5
.

4.

Hudson
F
,
Coulshed
D
,
D'Souza
E
et al.
Effect of radiation therapy on the latest generation of pacemakers and implantable cardioverter defibrillators: A systematic review
.
J Med Imaging Radiat Oncol
2010
;
54
:
53
61
.

5.

Rodriguez
F
,
Filimonov
A
,
Henning
A
et al.
Radiation-induced effects in multiprogrammable pacemakers and implantable defibrillators
.
Pacing Clin Electrophysiol
1991
;
14
:
2143
53
.

6.

Last
A
.
Radiotherapy in patients with cardiac pacemakers
.
Br J Radiol
1998
;
71
:
4
10
.

7.

Sundar
S
,
Symonds
RP
,
Deehan
C
.
Radiotherapy to patients with artificial cardiac pacemakers
.
Cancer Treat Rev
2005
;
31
:
474
86
.

8.

Miften
M
,
Mihailidis
D
,
Kry
SF
et al.
Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A report of the AAPM TG-203
.
Med Phys
2019
;
46
:
e757
e88
.

9.

Hurkmans
CW
,
Scheepers
E
,
Springorum
BG
et al.
Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators
.
Int J Radiat Oncol Biol Phys
2005
;
63
:
282
9
.

10.

Mouton
J
,
Haug
R
,
Bridier
A
et al.
Influence of high-energy photon beam irradiation on pacemaker operation
.
Phys Med Biol
2002
;
47
:
2879
93
.

11.

Souliman
SK
,
Christie
J
.
Pacemaker failure induced by radiotherapy
.
Pacing Clin Electrophysiol
1994
;
17
:
270
3
.

12.

Grant
JD
,
Jensen
GL
,
Tang
C
et al.
Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: Clinical incidence and predictors
.
JAMA Oncol
2015
;
1
:
624
32
.

13.

Gomez
DR
,
Poenisch
F
,
Pinnix
CC
et al.
Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: Incidence and predictors
.
Int J Radiat Oncol Biol Phys
2013
;
87
:
570
5
.

14.

Gelblum
DY
,
Amols
H
.
Implanted cardiac defibrillator care in radiation oncology patient population
.
Int J Radiat Oncol Biol Phys
2009
;
73
:
1525
31
.

15.

Elders
J
,
Kunze-Busch
M
,
Jan Smeenk
R
et al.
High incidence of implantable cardioverter defibrillator malfunctions during radiation therapy: Neutrons as a probable cause of soft errors
.
Europace
2012
;
15
:
60
5
.

16.

Ito
M
,
Kawamura
T
,
Mori
Y
et al.
Dose distributions of high-precision radiotherapy treatment: A comparison between the CyberKnife and TrueBeam systems
.
International Journal of Radiation Research
2018
;
16
:
395
402
.

17.

Marbach
JR
,
Sontag
MR
,
Van Dyk
J
et al.
Management of radiation oncology patients with implanted cardiac pacemakers: Report of AAPM task group no. 34. American Association of Physicists in Medicine
.
Med Phys
1994
;
21
:
85
90
.

18.

Zecchin
M
,
Severgnini
M
,
Fiorentino
A
et al.
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM)
.
Int J Cardiol
2018
;
255
:
175
83
.

19.

Gauter-Fleckenstein
B
,
Israel
CW
,
Dorenkamp
M
et al.
DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices
.
Strahlenther Onkol
2015
;
191
:
393
404
.

20.

Hurkmans
CW
,
Knegjens
JL
,
Oei
BS
et al.
Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in the Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO)
.
Radiat Oncol
2012
;
7
:
198
.

21.

Uiterwaal
G
,
Springorum
B
,
Scheepers
E
et al.
Interference detection in implantable defibrillators induced by therapeutic radiation therapy
.
Neth Heart J
2006
;
14
:
330
.

22.

Yamaji
S
,
Imai
S
,
Saito
F
et al.
Does high-power computed tomography scanning equipment affect the operation of pacemakers?
Circ J
2006
;
70
:
190
7
.

23.

Indik
JH
,
Gimbel
JR
,
Abe
H
et al.
2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices
.
Heart Rhythm
2017
;
14
:
e97
e153
.

24.

Organization, WH
.
Radiotherapy risk profile
.
Geneva
:
WHO
,
2008
.

25.

Georg
D
,
Knoos
T
,
McClean
B
.
Current status and future perspective of flattening filter free photon beams
.
Med Phys
2011
;
38
:
1280
93
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]